MiNK Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
MiNK Therapeutics, Inc. (INKT) reported Basic Shares Outstanding (Weighted Average) of 5.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 5.02M shares, a 26.15% increase year-over-year.
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.80M shares, a 21.01% increase year-over-year.
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 4.69M shares, a 18.38% increase year-over-year.
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 4.44M shares, a 12.39% increase year-over-year.
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 4.27M shares, a 13.18% increase from fiscal 2024.
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 3.77M shares, a 9.82% increase from fiscal 2023.
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 3.44M shares, a 89.80% decline from fiscal 2022.
- MiNK Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 33.67M shares, a 29.38% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.02M shares 10-Q · filed 2026-08-13 | 4.91M shares 10-Q · filed 2026-08-13 | 4.84M shares derived: average of 3 quarters · filed 2026-08-13 | 4.74M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 4.80M shares 10-Q · filed 2026-05-15 | 4.74M shares derived: average of 2 quarters · filed 2026-05-15 | 4.64M shares derived: average of 3 quarters · filed 2026-05-15 | 4.48M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 4.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 4.56M shares derived: average of 2 quarters · filed 2026-03-31 | 4.37M shares derived: average of 3 quarters · filed 2026-08-13 | 4.27M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 4.44M shares 10-Q · filed 2025-11-14 | 4.21M shares derived: average of 2 quarters · filed 2026-08-13 | 4.13M shares 10-Q · filed 2025-11-14 | 4.09M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 3.98M shares 10-Q · filed 2026-08-13 | 3.97M shares 10-Q · filed 2026-08-13 | 3.97M shares derived: average of 3 quarters · filed 2026-08-13 | 3.96M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 3.96M shares 10-Q · filed 2026-05-15 | 3.96M shares derived: average of 2 quarters · filed 2026-05-15 | 3.96M shares derived: average of 3 quarters · filed 2026-05-15 | 3.90M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 3.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 3.96M shares derived: average of 2 quarters · filed 2026-03-31 | 3.88M shares derived: average of 3 quarters · filed 2026-03-31 | 3.77M shares 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | 3.95M shares 10-Q · filed 2025-11-14 | 39.53M shares 10-Q · filed 2024-11-14 | 3.83M shares derived: average of 2 quarters · filed 2025-11-14 | 3.71M shares 10-Q · filed 2025-11-14 | 37.12M shares 10-Q · filed 2024-11-14 | -19.50M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 3.71M shares 10-Q · filed 2025-08-14 | 37.14M shares 10-Q · filed 2024-08-13 | 3.59M shares 10-Q · filed 2025-08-14 | 35.89M shares 10-Q · filed 2024-08-13 | -27.32M shares derived: average of 3 quarters · filed 2025-08-14 | -11.86M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 3.46M shares 10-Q · filed 2025-05-15 | 34.64M shares 10-Q · filed 2024-05-14 | -42.84M shares derived: average of 2 quarters · filed 2025-05-15 | -17.06M shares derived: average of 3 quarters · filed 2025-05-15 | -4.19M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -89.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -27.32M shares derived: average of 2 quarters · filed 2025-03-18 | -6.74M shares derived: average of 3 quarters · filed 2025-03-18 | 3.44M shares 10-K · filed 2025-03-18 | 34.36M shares 10-K · filed 2024-03-21 | |||
| 2023-09-30 | 34.50M shares 10-Q · filed 2024-11-14 | 34.45M shares derived: average of 2 quarters · filed 2024-11-14 | 34.29M shares 10-Q · filed 2024-11-14 | 34.17M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 34.41M shares 10-Q · filed 2024-08-13 | 34.19M shares 10-Q · filed 2024-08-13 | 34.06M shares derived: average of 3 quarters · filed 2024-08-13 | 33.99M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 33.97M shares 10-Q · filed 2024-05-14 | 33.89M shares derived: average of 2 quarters · filed 2024-05-14 | 33.84M shares derived: average of 3 quarters · filed 2024-05-14 | 33.79M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 33.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 33.78M shares derived: average of 2 quarters · filed 2024-03-21 | 33.73M shares derived: average of 3 quarters · filed 2024-03-21 | 33.67M shares 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | 33.76M shares 10-Q · filed 2023-11-14 | 33.69M shares derived: average of 2 quarters · filed 2023-11-14 | 33.63M shares 10-Q · filed 2023-11-14 | 33.11M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 33.62M shares 10-Q · filed 2023-08-10 | 33.56M shares 10-Q · filed 2023-08-10 | 32.89M shares derived: average of 3 quarters · filed 2023-08-10 | 30.72M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 33.50M shares 10-Q · filed 2023-05-11 | 32.52M shares derived: average of 2 quarters · filed 2023-05-11 | 29.75M shares derived: average of 3 quarters · filed 2023-05-11 | 28.36M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 31.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 27.87M shares derived: average of 2 quarters · filed 2023-03-24 | 26.64M shares derived: average of 3 quarters · filed 2023-03-24 | 26.03M shares 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | 24.21M shares 10-Q · filed 2022-11-03 | 24.19M shares derived: average of 2 quarters · filed 2022-11-03 | 24.19M shares 10-Q · filed 2022-11-03 | |||||
| 2021-06-30 | 24.18M shares 10-Q · filed 2022-08-15 | 24.18M shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |